Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...

The need to change regulations around gene-editing treatments was endorsed in November by the head of the US Food and Drug ...

The gene therapy success with Baby KJ, along with a new FDA program, have companies more interested in treating rare disease.

The biotech startup Inscripta is attempting to “democratize” CRISPR by offering it to select researchers at no cost, according to Fortune. Here are four things to know about the startup’s business ...